Clinical Trial Update: Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection [NA]

View source ↗

Summary

A clinical trial is evaluating Axoguard HA Plus Nerve Protector to reduce post-operative neck and shoulder dysfunction in patients undergoing neck dissection fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Axoguard HA Plus Nerve Protector

Snippet

Sponsor: Matthew Spector | Conditions: Head and Neck Cancer, Neck Dissection | NA | Status: RECRUITING